Related Experiment Video
Updated: Jun 14, 2026

10:17
Analysis of Schwann-astrocyte Interactions Using In Vitro Assays
Published on: January 13, 2011
Modulation of factors affecting optic nerve head astrocyte migration.
Haixi Miao1, Andrea W Crabb, M Rosario Hernandez
1Department of Ophthalmology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Investigative Ophthalmology & Visual Science
|April 9, 2010
Summary
Myosin light chain kinase (MYLK) and transforming growth factor beta (TGFbeta) pathways influence optic nerve head astrocyte migration. Elevated hydrostatic pressure increases MYLK expression, suggesting MYLK as a potential glaucoma intervention target.
Area of Science:
- Ophthalmology
- Cell Biology
- Molecular Biology
Background:
- Optic nerve head (ONH) astrocyte migration is implicated in glaucoma pathogenesis.
- Myosin light chain kinase (MYLK) and transforming growth factor beta (TGFbeta) signaling pathways are critical regulators of cell migration.
Purpose of the Study:
- To investigate the roles of MYLK and TGFbeta receptor pathways in ONH astrocyte migration.
- To determine how elevated hydrostatic pressure (HP) affects the expression of MYLK and TGFbeta pathway components in ONH astrocytes.
Main Methods:
- Polymerase chain reaction (PCR) was used to identify MYLK isoforms in ONH astrocytes.
- Small interfering RNAs (siRNAs) targeting MYLK and TGFbeta receptor 2 (TGFBR2) were employed to assess their impact on astrocyte migration.
- The effects of elevated HP on MYLK isoform and TGFbeta pathway component expression were quantified.
Main Results:
- ONH astrocytes express multiple MYLK isoforms (MYLK-130, MYLK-210, and a splicing variant).
- MYLK and TGFBR2 inhibition reduced astrocyte migration and TGFbeta-regulated gene expression.
- Elevated HP increased MYLK expression in both Caucasian and African American astrocytes, while TGFbeta2 was uniquely upregulated in Caucasian astrocytes.
Conclusions:
- The differential expression of MYLK and TGFbeta pathway genes under elevated HP mirrors findings in glaucomatous astrocytes.
- MYLK represents a potential therapeutic target for modulating ONH astrocyte migration in glaucoma.

